Hemab Therapeutics Holdings (COAG) Other Accumulated Expenses (2025 - 2026)
Hemab Therapeutics Holdings' Other Accumulated Expenses came in at $1.2 million for Q3 2026, up 21.4% from the prior quarter.
Powered by 
Analysis
Hemab Therapeutics Holdings (COAG) Other Accumulated Expenses (2025 - 2026) Analysis & Trends
At the end of FY2025, Hemab Therapeutics Holdings' Other Accumulated Expenses was $340,000.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Hemab Therapeutics Holdings | 1.91 Bn | 672.70 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.20 Mn |
| Jun 30, 2026 | 990,000.00 |
| Dec 31, 2025 | 340,000.00 |
API Access
Hemab Therapeutics Holdings Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=COAG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "COAG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=COAG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();